216 related articles for article (PubMed ID: 14982733)
1. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
Burdo TH; Gartner S; Mauger D; Wigdahl B
J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
[TBL] [Abstract][Full Text] [Related]
3. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.
Ross HL; Gartner S; McArthur JC; Corboy JR; McAllister JJ; Millhouse S; Wigdahl B
J Neurovirol; 2001 Jun; 7(3):235-49. PubMed ID: 11517398
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.
Hogan TH; Nonnemacher MR; Krebs FC; Henderson A; Wigdahl B
Biomed Pharmacother; 2003 Jan; 57(1):41-8. PubMed ID: 12642036
[TBL] [Abstract][Full Text] [Related]
6. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
[TBL] [Abstract][Full Text] [Related]
7. C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells.
Quiterio S; Grant C; Hogan TH; Krebs FC; Wigdahl B
Biomed Pharmacother; 2003 Jan; 57(1):49-56. PubMed ID: 12642037
[TBL] [Abstract][Full Text] [Related]
8. Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.
Shah S; Alexaki A; Pirrone V; Dahiya S; Nonnemacher MR; Wigdahl B
Virol J; 2014 May; 11():92. PubMed ID: 24886416
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
[TBL] [Abstract][Full Text] [Related]
10. CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
Dahiya S; Liu Y; Nonnemacher MR; Dampier W; Wigdahl B
PLoS One; 2014; 9(2):e88116. PubMed ID: 24551078
[TBL] [Abstract][Full Text] [Related]
11. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.
Henderson AJ; Zou X; Calame KL
J Virol; 1995 Sep; 69(9):5337-44. PubMed ID: 7636977
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
[TBL] [Abstract][Full Text] [Related]
13. Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat.
Nonnemacher MR; Hogan TH; Quiterio S; Wigdahl B; Henderson A; Krebs FC
Biomed Pharmacother; 2003 Jan; 57(1):34-40. PubMed ID: 12642035
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
15. Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity.
Ravimohan S; Gama L; Engle EL; Zink MC; Clements JE
PLoS One; 2012; 7(8):e42801. PubMed ID: 22952612
[TBL] [Abstract][Full Text] [Related]
16. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
18. Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms.
Shah S; Pirrone V; Alexaki A; Nonnemacher MR; Wigdahl B
Biomed Res Int; 2015; 2015():320642. PubMed ID: 25629043
[TBL] [Abstract][Full Text] [Related]
19. Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression.
Ravimohan S; Gama L; Barber SA; Clements JE
J Biol Chem; 2010 Jan; 285(4):2258-73. PubMed ID: 19933495
[TBL] [Abstract][Full Text] [Related]
20. Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment.
Li L; Aiamkitsumrit B; Pirrone V; Nonnemacher MR; Wojno A; Passic S; Flaig K; Kilareski E; Blakey B; Ku J; Parikh N; Shah R; Martin-Garcia J; Moldover B; Servance L; Downie D; Lewis S; Jacobson JM; Kolson D; Wigdahl B
J Neurovirol; 2011 Feb; 17(1):92-109. PubMed ID: 21225391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
